Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(16.67%)
USD 0.0
(16.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -190 Thousand | -349 Thousand | -421 Thousand | -388 Thousand | -316 Thousand | -682 Thousand |
| Net Income | -1.16 Million | -2.73 Million | -3.63 Million | 4.31 Million | -1.22 Million | -8.33 Million |
| Depreciation & Amortization | 1000.00 | 3000.00 | 2000.00 | 2000.00 | 2000.00 | 622 Thousand |
| Deferred income taxes | - | - | - | -24 Thousand | -367 Thousand | - |
| Stock-based compensation | - | - | - | 24 Thousand | 367 Thousand | - |
| Change in working capital | 512 Thousand | 328 Thousand | 168 Thousand | 260 Thousand | 340 Thousand | 144 Thousand |
| Other non-cash items | 462 Thousand | 2.05 Million | 3.04 Million | -4.96 Million | 564 Thousand | 6.88 Million |
| Investing Cash Flow | 102 Thousand | 332 Thousand | 300 Thousand | 480 Thousand | 340 Thousand | 500 Thousand |
| Investments in PPE | - | - | - | -4000.00 | - | - |
| Acquisitions | - | 300 Thousand | 300 Thousand | 300 Thousand | 300 Thousand | 500 Thousand |
| Investment purchases | - | - | - | -300 Thousand | - | - |
| Sales/Maturities of investments | 102 Thousand | 32 Thousand | - | 184 Thousand | 40 Thousand | - |
| Other Investing Activities | 102 Thousand | 300 Thousand | 300 Thousand | 300 Thousand | 300 Thousand | 500 Thousand |
| Financing Cash Flow | -20 Thousand | -40 Thousand | - | 24 Thousand | 150 Thousand | - |
| Debt repayment | -20 Thousand | -40 Thousand | - | - | -150 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 24 Thousand | 360 Thousand | - |
| Other Financing Activities | -20 Thousand | -40 Thousand | - | -24 Thousand | -60 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 490 Thousand | 17 Thousand | -105 Thousand | -10.25 Thousand | 342 Thousand | 33 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 22 Thousand | 311 Thousand | 273 Thousand | 270.25 Thousand | -2000.00 | 111 Thousand |
| Cash at beginning of period | 175 Thousand | 232 Thousand | 353 Thousand | 261 Thousand | 87 Thousand | 269 Thousand |
| Cash at end of period | 67 Thousand | 175 Thousand | 232 Thousand | 353 Thousand | 261 Thousand | 87 Thousand |
| Capital Expenditure | - | - | - | -4000.00 | - | - |
| Effect of forex changes on cash | - | - | - | -24 Thousand | - | - |
| Net cash flow / Change in cash | -108 Thousand | -57 Thousand | -121 Thousand | 92 Thousand | 174 Thousand | -182 Thousand |
| Free Cash Flow | -190 Thousand | -349 Thousand | -421 Thousand | -392 Thousand | -316 Thousand | -682 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -158 Thousand | -382 Thousand | -1.16 Million | -254 Thousand | -262 Thousand | -229 Thousand |
| Depreciation & Amortization | - | - | 1000.00 | - | - | 1000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 143 Thousand | 150 Thousand | 512 Thousand | 137 Thousand | 143 Thousand | 121 Thousand |
| Other non-cash items | -2000.00 | 190 Thousand | 462 Thousand | 103 Thousand | 82 Thousand | 43 Thousand |
| Investing Cash Flow | 4000.00 | 26 Thousand | 102 Thousand | -8000.00 | 84 Thousand | 26 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 4000.00 | 26 Thousand | 102 Thousand | -8000.00 | 84 Thousand | 26 Thousand |
| Other Investing Activities | - | 26 Thousand | 102 Thousand | -8000.00 | 84 Thousand | 26 Thousand |
| Financing Cash Flow | - | - | -20 Thousand | - | -10 Thousand | - |
| Debt repayment | - | - | -20 Thousand | -20 Thousand | -10 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -20 Thousand | - | -10 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | 14 Thousand | 490 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 143 Thousand | 150 Thousand | 22 Thousand | 137 Thousand | 143 Thousand | 121 Thousand |
| Cash at beginning of period | 51 Thousand | 67 Thousand | 175 Thousand | 89 Thousand | 52 Thousand | 90 Thousand |
| Cash at end of period | 38 Thousand | 51 Thousand | 67 Thousand | 67 Thousand | 89 Thousand | 52 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | 299 Thousand | -299 Thousand | - |
| Net cash flow / Change in cash | -13 Thousand | -16 Thousand | -108 Thousand | -22 Thousand | 37 Thousand | -38 Thousand |
| Free Cash Flow | -17 Thousand | -42 Thousand | -190 Thousand | -14 Thousand | -37 Thousand | -64 Thousand |
1776
6810
LLOYDSME
E5H
8018
MRGN